Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Trace Elem Med Biol ; 55: 58-63, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31345366

ABSTRACT

BACKGROUND: Alzheimer's disease (AD) is the most common age-related neurodegenerative disease. An altered homeostasis of Zinc (Zn) and Copper (Cu), as well as a dysregulated expression of Zn-regulatory proteins have been previously described in AD. Acetylcholinesterase inhibitors (AChEI) are commonly used as AD treatment to improve cognitive function, but their effect on Zn homeostasis is still unexplored. OBJECTIVES: The aims of this study were to define the metal dyshomeostasis in AD patients, to investigate AChEI influence on Zn homeostasis and inflammation, and to analyze the relationship between cognitive impairment at two-year follow-up and metal concentrations, considering AChEI use. METHODS AND RESULTS: 84 Healthy Elderly (HE) and 95 AD patients were enrolled (62 AchEI user and 33 AchEI naïve). HE showed similar plasma Zn and Cu concentrations and Cu/Zn ratio in comparison to AChEI users, but significantly higher Zn level, as well as lower Cu amount and Cu/Zn ratio than AChEI naïve patients. Moreover, AChEI users had increased Zn plasma level, reduced Cu amount, Cu/Zn ratio, and IL1ß concentration and lower Zip2 lymphocytic expression vs. naïve patients. A multiple linear regression analysis showed that the MMSE score decline after two-year follow-up was reduced by AChEI therapy and was positively associated with plasma Zn decrease over time. CONCLUSION: Our data revealed that AChEI use may affect peripheral Zn and Cu homeostasis in AD patients, decrease Cu/Zn ratio demonstrating a general reduction of inflammatory status in patients under AChEI treatment. Finally, AChEI influence on circulating Zn could be implicated in the drug-related slowdown of cognitive decline.


Subject(s)
Acetylcholinesterase/metabolism , Alzheimer Disease/drug therapy , Cholinesterase Inhibitors/pharmacology , Copper/blood , Homeostasis/drug effects , Zinc/blood , Aged , Alzheimer Disease/blood , Alzheimer Disease/enzymology , Alzheimer Disease/metabolism , Cholinesterase Inhibitors/administration & dosage , Copper/metabolism , Female , Humans , Inflammation/drug therapy , Inflammation/metabolism , Linear Models , Male , Zinc/metabolism
2.
Aging Clin Exp Res ; 29(3): 353-360, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27106901

ABSTRACT

BACKGROUND: Cognitive decline and dementia represent a key problem for public health as they heavily impair social functioning and independent living. The development of new strategies to support recommendations for patients and their caregivers may represent an outstanding step forward. AIMS: To describe the study protocol and methods of "My Mind Project: the effect of cognitive training for elderly" (Grant No. 154/GR-2009-1584108), which investigates, by the use of a multidisciplinary approach, the effects of a comprehensive cognitive training programme on performances in aged subjects with mild-moderate Alzheimer's disease, mild cognitive impairment and normal cognitive functioning. METHODS: The study is a prospective randomized intervention for the assessment of cognitive training effects in three groups of elderly subjects with different cognitive status. A total of 321 elderly people were enrolled in Marche Region, Italy. Each subject was randomly assigned to an experimental group or to a control group. Cognitive performances and biochemical blood markers have also been analysed before cognitive training (baseline), immediately after termination (follow-up 1), after 6 months (follow-up 2) and after 2 years (follow-up 3). DISCUSSION: The results will be useful to identify some efficient programmes for the enhancement of cognitive performance in elderly with and without cognitive decline. CONCLUSION: The application of a non-pharmacological approach in the treatment of elderly with cognitive disorders could have a profound impact on National Health Service.


Subject(s)
Alzheimer Disease/therapy , Cognitive Dysfunction/therapy , Aged , Alzheimer Disease/psychology , Clinical Protocols , Cognitive Dysfunction/psychology , Humans , Italy , Memory , Prospective Studies
3.
Rejuvenation Res ; 13(2-3): 144-7, 2010.
Article in English | MEDLINE | ID: mdl-19954306

ABSTRACT

Alzheimer disease (AD) is associated with mitochondrial dysfunction. In this study, we investigated succinic dehydrogenase (SDH) activity in mitochondria of hippocampal CA1 pyramidal neurons obtained from 10-month-old 3xTg-AD mice, an animal model of AD, as well as from age-matched control mice PS1-KI. In SDH-positive mitochondria, we measured numeric density (Nv, number of mitochondria/microm(3) of cytoplasm), average organelle volume (V), volume density (Vv, volume fraction of mitochondria/microm(3) of cytoplasm), average length (Fmax), and the ratio (R) between the total area of the cytochemical precipitate due to SDH activity and the total mitochondrial area. Our results indicate that 3xTg-AD mitochondria show a significant decrease of Nv, increase in V and Fmax, as well as a trend toward a reduction of R, whereas Vv is unchanged. Our findings further support the idea that mitochondrial dysfunction is involved in AD and are in line with studies indicating that both amyloid precursor protein (APP) and amyloid-beta (Abeta) localize to mitochondria.


Subject(s)
Alzheimer Disease/pathology , Disease Models, Animal , Mice, Transgenic , Mitochondria/physiology , Pyramidal Cells/ultrastructure , Succinate Dehydrogenase/metabolism , Alzheimer Disease/genetics , Animals , CA1 Region, Hippocampal/metabolism , CA1 Region, Hippocampal/pathology , Matched-Pair Analysis , Mice , Mitochondria/metabolism , Mitochondria/pathology , Pyramidal Cells/metabolism , Pyramidal Cells/pathology
4.
Rejuvenation Res ; 9(1): 102-6, 2006.
Article in English | MEDLINE | ID: mdl-16608405

ABSTRACT

The ultrastructural features of layer II synapses in the perirhinal cortex of adult (4- to 6-month-old) and old (25- to 27-month-old) rats exposed to a six-session object recognition visual training were investigated by morphometric methods. The comparative analysis showed a higher synaptic numeric density, a lower synaptic average area, and a lower percentage of megasynapses (S > 0.5 microm2) in old trained rats versus controls, and a higher percentage of small (S < 0.15 microm2) junctions in adult trained rats versus controls. The more marked synaptic remodeling underlying memory consolidation in the perirhinal cortex of old rats might reflect a pre-existing lower dynamic status.


Subject(s)
Aging/pathology , Aging/psychology , Entorhinal Cortex/cytology , Memory , Synapses/ultrastructure , Animals , Male , Rats , Rats, Wistar , Recognition, Psychology , Temporal Lobe/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...